Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4051–4100 of 75328
The Board has appointed Matthew Wood a Senior Vice President of the Company, and Mr. Wood will succeed Mr. Kalkstein as President, Reinforcement Materials Segment.
On May 30, 2025, Hobart C. Kalkstein, Executive Vice President and President, Reinforcement Materials Segment of Cabot Corporation (the "Company"), informed the Company’s Board of Directors (the "Board") of his decision to step down from those positions, effective June 15, 2025.
Althea Brown submitted her resignation as the Chief Legal Officer and Corporate Secretary of LPL Financial Holdings Inc. (the “Company”) effective June 30, 2025, when she will depart the Company.
On May 30, 2025, Jan Ryan was appointed to the Board of Directors (the "Board") of Westwood Holdings Group, Inc. (“Westwood”), effective immediately.
The Second Amended Agreement reflects changes in Ms. Lachance’s compensation and other terms of employment in connection with her previously announced transition from President and Chief Operating Officer of the Company to President and Chief Executive Officer of the Company that occurred on May 19, 2025.
In connection with Ms. Gilmore’s termination, Dustin Libby joined the Company as Executive Vice President of Commercial Operations on June 3, 2025.
On May 30, 2025, Nanci Gilmore, the Chief Commercial Officer of Sanuwave Health, Inc. (the “Company”), was terminated without cause, effective as of the same date.
On June 2, 2025, Todd E. Telesz , our Senior Vice President and Chief Financial Officer, informed us that he intends to resign from us on June 13, 2025, to take a position as the Chief Financial Officer for a vertically integrated independent power producer headquartered in Colorado.
On May 27, 2025, the Board of Directors of Eva Live Inc. (the “Company”) increased its board size from four to five directors and appointed Riz Jamal (Director), age 45, to the position of Director of the Company.
On June 2, 2025, InspireMD, Inc. (the “ Company ”) appointed Michael Lawless as Chief Financial Officer of the Company, effective on or before June 30, 2025 (the “ Effective Date ”).
On the Effective Date, Mr. Lawless will succeed Craig Shore, whose employment as the Company’s Chief Financial Officer will be terminated simultaneous with Mr. Lawless’s appointment.
On May 30, 2025, Rick Parod resigned from the Board of Directors (the “Board”) of Dragonfly Energy Holdings Corp. (the “Company”), effective May 31, 2025.
On May 30, 2025, the Board of Directors (the “Board”) of Entrada Therapeutics, Inc. (the “Company”) expanded the size of the Board from six to seven directors and appointed Maha Radhakrishnan, M.D. to the Board as a Class III director, to serve until the Company’s annual meeting of stockholders to be held in 2027 or until her successor is duly elected and qualified, in each case effective as of June 1, 2025.
Ms. Lori L. Colvin, Vice President/Controller/Chief Accounting Officer for the Companies, informed the Companies of her intention to retire effective June 1, 2025.
Due to her retirement, on May 29, 2025, the board of directors of each of the Companies appointed Mr. Robert J. Stefani, 51, Senior Vice President/Chief Financial Officer for the Companies, to also serve as Controller for the Companies, effective June 1, 2025.
Mr. Horowitz subsequently notified the Company on June 3, 2025 (the “Effective Date”) of his resignation, effective immediately, from the Company’s Board of Directors (the “Board”).
On May 28, 2025, Patrick Walters notified the Board of Directors of NeOnc Technologies Holdings, Inc. (the “Company”) of his decision to retire as Chief Operating Officer of the Company effective June 1, 2025.
Effective June 1, 2025, the Company announced that the Company’s Board of Directors had appointed Jerry J. Harrison, Jr. to serve as Interim Chief Financial Officer.
As previously disclosed, on May 16, 2025, Brian J. Gyomory, the Executive Vice President and Chief Financial Officer of 1st Franklin Financial Corporation (the "Company"), informed the Company of his intent to retire from the Company, effective May 31, 2025.
On May 27, 2025, Lori Robinson resigned from the Board of Directors of NACCO Industries, Inc. (the “Company”), effective immediately.
Effective as of June 1, 2025, First Interstate BancSystem, Inc. (the “Company”), First Interstate Bank (the “Bank”) and David P. Della Camera completed and formally executed the Employment Agreement
On June 1, 2025, Camelot Return Intermediate Holdings, LLC (“Parent”), as the sole stockholder of Cornerstone Building Brands, Inc. (the “Company”), acting by written consent in lieu of an annual meeting, elected Suzanne Stefany as a director of the Company to fill a vacancy on the board of directors
the following individuals, each of whom was a member of the board of directors of FLIC immediately prior to consummation of the Merger, were appointed to the board of directors of ConnectOne: Christopher Becker, Edward J. Haye and Peter Quick.
FLIC’s directors and executive officers ceased serving as directors and executive officers of FLIC. In addition, as of the Effective Time and in accordance with the Merger Agreement, the following individuals, each of whom was a member of the board of directors of FLIC immediately prior to consummation of the Merger, were appointed to the board of directors of ConnectOne: Christopher Becker, Edward J. Haye and Peter Quick.
FLIC’s directors and executive officers ceased serving as directors and executive officers of FLIC. In addition, as of the Effective Time and in accordance with the Merger Agreement, the following individuals, each of whom was a member of the board of directors of FLIC immediately prior to consummation of the Merger, were appointed to the board of directors of ConnectOne: Christopher Becker, Edward J. Haye and Peter Quick.
Mr. Becker is serving as the non-executive Vice Chairman of the Board of Directors of ConnectOne.
FLIC’s directors and executive officers ceased serving as directors and executive officers of FLIC. In addition, as of the Effective Time and in accordance with the Merger Agreement, the following individuals, each of whom was a member of the board of directors of FLIC immediately prior to consummation of the Merger, were appointed to the board of directors of ConnectOne: Christopher Becker, Edward J. Haye and Peter Quick.
the following individuals, each of whom was a member of the board of directors of FLIC immediately prior to consummation of the Merger, were appointed to the board of directors of ConnectOne: Christopher Becker, Edward J. Haye and Peter Quick.
On May 31, 2025, Marques Coleman, who currently serves as a Class II director on the Board of Directors (the “Board”) of ADT Inc. (the “Company”) with a term expiring at the Company’s 2028 Annual Meeting of Stockholders, retired from his position as a member of the Board.
Effective upon his departure, Alisa Campbell, currently Senior Vice President, Corporate Finance & Accounting, will assume leadership of the Company’s accounting and finance function on an interim basis reporting to Ziad Ghanem, President and Chief Executive Officer.
On May 28, 2025, Keith Stauffer notified the Company of his decision to resign as the Company’s Chief Financial Officer (“CFO”), effective July 18, 2025
As previously announced, George E. Kilguss III, Executive Vice President and Chief Financial Officer of VeriSign, Inc. (the “Company”), retired from the Company effective May 31, 2025.
Erik Guffrey , currently Chief Technology Officer, Adaptive Learning & Insights and Medical Communications Products, assumes the new role of Co-Chief Product and Technology Officer.
Dr. Jonathan Chauvin , currently Business Unit Co-President, Clinical Pharmacology & Pharmacometric Solutions, assumes the new role of Co-Chief Product and Technology Officer.
Josh Fohey , currently Senior Vice President, Operations, assumes the new role of Chief Operating Officer.
On May 30, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Simulations Plus, Inc. (the “Company”) appointed John DiBella as Chief Revenue Officer of the Company, effective immediately.
Steven Chang , currently Business Unit President, Quantitative Systems Pharmacology Solutions, assumes the new role of Global Head of Strategic Alliances.
Jill Fiedler-Kelly , currently Business Unit Co-President, Clinical Pharmacology & Pharmacometric Solutions, assumes the new role of Interim President, Services Solutions.
Will Frederick , currently Chief Financial Officer and Chief Operating Officer, assumes the new role of Executive Vice President and Chief Financial Officer.
On the Effective Date, the Company and Daniel Szot, the Company’s Chief Revenue Officer, mutually agreed to Mr. Szot’s separation from the Company, to take effect at the end of the third fiscal quarter which allows for smooth transition as Mr. Szot seeks to pursue other opportunities.
On June 2, 2025, the Board of Directors (the “Board”) of United Parcel Service, Inc. (“UPS”), upon recommendation of the Board’s Nominating and Corporate Governance Committee, increased the size of the Board to thirteen members and appointed John Morikis, age 61, to the Board, effective immediately.
On May 30, 2025, William H. Flores resigned as a member of the Board of Directors of New Era Helium, Inc. (the “ Company ”) with an effective date of May 30, 2025.
appointed Robert Kauffman, a current independent director of the Company’s Board and Chair of the Finance Committee, as the Company’s Non-Executive Chairperson of the Board, effective May 30, 2025.
Ms. Sue Perrotty, who resigned from her position as Non-Executive Chairperson but will continue to serve on the Board as an independent director.
Antony Koblish, the Company’s current President and Chief Executive Officer, will continue in his role as Chief Executive Officer, but as of the Effective Date will no longer hold the title of President.
Jeffrey Blizard, a member of the Board of Directors (the “ Board ”) of TELA Bio, Inc. (the “ Company ”), tendered his resignation from the Board, effective as of June 2, 2025.
the Board appointed Jeffrey Blizard as the new President of the Company, effective as of June 2, 2025
appointed Asim Akram as the Company’s Chief Executive Officer and President, effective June 23, 2025
Stuart V. Flavin III, the Company’s Interim Chief Executive Officer and Interim President, agreed to transition out of these positions on the CEO Effective Date but will remain a member of the Board.
On May 30, 2025, the board of directors (the “Board”) of The Cigna Group (the “Company”) appointed Michael J. Hennigan as an independent member of the Board, effective June 2, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.